Literature DB >> 24276755

miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.

Bitao Chen1, Tao Huang, Jun Jiang, Lei Lv, Hongxing Li, Shitao Xia.   

Abstract

miR-141 belongs to the miR-200 family, and has been found to be associated with numerous human malignancies; however, its role in gastric cancer (GC) has not been examined in detail. Here, we validated that miR-141 was decreased in GC tissues and cell lines. Forced expression of miR-141 significantly repressed GC cell proliferation and colony formation. Furthermore, miR-141 suppressed in vitro migration and invasion of GC cells. Hepatoma-derived growth factor (HDGF) was confirmed to be a direct target of miR-141 in GC cells. The suppressive effects of miR-141 on GC cell proliferation, colony formation, in vitro migration, and invasion were partially mediated by suppressing HDGF expression. Moreover, the expression of HDGF was negatively correlated with miR-141 in GC tissues. Our data suggest that miR-141 might be associated and plays essential role in GC progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24276755     DOI: 10.1007/s11010-013-1912-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.

Authors:  Tetsuya Ueda; Stefano Volinia; Hiroshi Okumura; Masayoshi Shimizu; Cristian Taccioli; Simona Rossi; Hansjuerg Alder; Chang-gong Liu; Naohide Oue; Wataru Yasui; Kazuhiro Yoshida; Hiroki Sasaki; Sachiyo Nomura; Yasuyuki Seto; Michio Kaminishi; George A Calin; Carlo M Croce
Journal:  Lancet Oncol       Date:  2009-12-18       Impact factor: 41.316

2.  Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation.

Authors:  Jianshan Mao; Zefeng Xu; Yongming Fang; Haijun Wang; Jinghong Xu; Jinjia Ye; Shu Zheng; Yongliang Zhu
Journal:  Cancer Sci       Date:  2008-11       Impact factor: 6.716

3.  The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.

Authors:  San-Zhong Li; Yong-Bo Zhao; Wei-Dong Cao; Yan Qu; Peng Luo; Hai-Ning Zhen; Xiao-Yan Chen; Zhi-Feng Yan; Zhou Fei
Journal:  Med Oncol       Date:  2013-06-15       Impact factor: 3.064

4.  MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells.

Authors:  Qiong Wu; Zhiping Yang; Fang Wang; Sijun Hu; Li Yang; Yongquan Shi; Daiming Fan
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

Review 5.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 6.  Emerging roles of microRNA in modulating cell-death processes in malignant glioma.

Authors:  Silvia Palumbo; Clelia Miracco; Luigi Pirtoli; Sergio Comincini
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

7.  Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.

Authors:  Hirofumi Yoshino; Hideki Enokida; Toshihiko Itesako; Shuichi Tatarano; Takashi Kinoshita; Miki Fuse; Satoko Kojima; Masayuki Nakagawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2013-05-02       Impact factor: 3.172

8.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

9.  miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1.

Authors:  Yang Ke; Weiyong Zhao; Jie Xiong; Rubo Cao
Journal:  Biochem Res Int       Date:  2013-05-16

10.  Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2).

Authors:  Xiangsheng Li; Zhichao Zhang; Ming Yu; Liqi Li; Guangsheng Du; Weidong Xiao; Hua Yang
Journal:  Int J Mol Sci       Date:  2013-08-06       Impact factor: 5.923

View more
  25 in total

1.  miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.

Authors:  Mengyuan Wang; Ming Hu; Zhaohua Li; Dongmeng Qian; Bin Wang; David X Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-06-07       Impact factor: 3.575

2.  MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

Authors:  Weidong Lu; Zhen Xu; Min Zhang; Yun Zuo
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Expression of miR-141 and YAP1 in gastric carcinoma and modulation of cancer cell proliferation and apoptosis.

Authors:  Fangchao Du; Chao Yu; Rui Li; Ding Ding; Lei He; Gang Wen
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 4.  Recent advances in the molecular diagnostics of gastric cancer.

Authors:  Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

5.  Anti-proliferative role and prognostic implication of miR-141 in gastric cancer.

Authors:  Mingwei Huang; Liucheng Wu; Yuzhou Qin; Zhao Li; Shanshan Luo; Haiquan Qin; Yang Yang; Jiansi Chen
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

6.  Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2.

Authors:  Aditya Shetty; Subramanyam Dasari; Souresh Banerjee; Taher Gheewala; Guoxing Zheng; Aoshuang Chen; Andre Kajdacsy-Balla; Maarten C Bosland; Gnanasekar Munirathinam
Journal:  Urol Oncol       Date:  2016-09-28       Impact factor: 3.498

7.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

8.  MiR-141 targets ZEB2 to suppress HCC progression.

Authors:  Shi-Min Wu; Hong-Wu Ai; Ding-Yu Zhang; Xiao-Qun Han; Qin Pan; Feng-Ling Luo; Xiao-Lian Zhang
Journal:  Tumour Biol       Date:  2014-07-10

9.  MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells.

Authors:  Haizhou Guo; Weihao Li; Tianliang Zheng; Zhangsuo Liu
Journal:  Tumour Biol       Date:  2014-06-03

10.  miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.

Authors:  Jun Xue; Yan-Feng Niu; Jing Huang; Gang Peng; Li-Xia Wang; Yu-Hui Yang; Yun-Qiao Li
Journal:  Tumour Biol       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.